This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...